Growth

Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference

MALVERN, Pa., June 28, 2007 /PRNewswire-FirstCall/ -- AuxiliumPharmaceuticals, Inc. today announced that Mr. Armando Anido, ChiefExecutive Officer and President, and Mr. Jim Fickenscher, ChiefFinancial Officer, will participate in the 2007 CEUT EmergingGrowth Opportunities Conference to be held July 10 through July 12,2007 at the Mandarin Oriental Hotel in New York City. Mr. Anido issche...

ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul 2, 2007 - ViaCell, Inc.(NASDAQ: VIAC) today announced that Marc D. Beer, President andChief Executive Officer of ViaCell, will present an update on itsbusiness activities and product pipeline at the C.E. Unterberg,Towbin Emerging Growth Opportunities Conference on Tuesday, July10, 2007 at 3:00 p.m. at the Mandarin Oriental Hotel in New York,NY. A live...

Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference

SAN DIEGO--(BUSINESS WIRE)--Jul 2, 2007 - Accelrys, Inc.(NASDAQ:ACCL), the leading provider of scientific businessintelligence software and services, announced today that its CFO,Rick Russo, will present at the C.E. Unterberg, Towbin EmergingGrowth Opportunities Conference in New York on July 11, 2007 at10:30 a.m. ET. The conference will take place at the MandarinOriental Hotel July 10th-12...

Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference

SAN DIEGO--(BUSINESS WIRE)--Jul 2, 2007 - Metabasis Therapeutics(NASDAQ:MBRX), a biopharmaceutical company focused on thediscovery, development and commercialization of novel drugs for thetreatment of metabolic and liver diseases by targeting the liverand liver pathways, announced today that John Beck, senior vicepresident of finance and chief financial officer of Metabasis willpresent at t...

Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

DURHAM, N.C.--(BUSINESS WIRE)--Jul 3, 2007 - InspirePharmaceuticals, Inc. (NASDAQ:ISPH) announced today that Christy L.Shaffer, Ph.D., President and CEO, will present at the C.E.Unterberg, Towbin Emerging Growth Opportunities Conference onWednesday, July 11, 2007 at 11:00 am ET in New York City. The webcast of the presentation will be available on Inspire'sweb site at www.inspirepharm.com...

Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference

SOUTH SAN FRANCISCO, Calif., July 03, 2007/PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. todayannounced that Eric Bjerkholt, Sunesis' Senior Vice President,Corporate Development and Finance, will present a company update atthe C. E. Unterberg, Towbin Emerging Growth Conference on July 12,2007 at 9:00 a.m. Eastern Time in New York, NY. Interested parties may access the webc...

EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

LEXINGTON, Mass.--(BUSINESS WIRE)--Jul 3, 2007 - EPIXPharmaceuticals, Inc. (NASDAQ:EPIX) today announced that Michael G.Kauffman, M.D., Ph.D., chief executive officer of EPIX, isscheduled to present at the C.E. Unterberg, Towbin Emerging GrowthOpportunities Conference on Tuesday, July 10, 2007 at 1:30 p.m.(EDT) at the Mandarin Oriental Hotel in New York, NY. The presentation will be webca...

Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin Emerging Growth Opportunities Conference

REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, July 03, 2007/PRNewswire-FirstCall/ -- Rosetta Genomics Ltd , a leading microRNAcompany, announced today that J. Michael French, Rosetta GenomicsPresident, will present at CE Unterberg, Towbin Emerging GrowthOpportunities Conference on Tuesday, July 10, at 11:00 am EST atthe Mandarin Oriental Hotel in New York. A live audio webcast o...

GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Jul 5, 2007 - GTCBiotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced today thatGeoffrey Cox, Ph.D., GTC's Chairman and CEO, is scheduled topresent on Wednesday, July 11, 2007 at 9:00 a.m. during the C.E.Unterberg, Towbin Emerging Growth Life Opportunities Conference.The conference is being held at the Mandarin Oriental Hotel, NewYork, New York from July...

Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference

BETHESDA, Md., July 05, 2007 /PRNewswire-FirstCall/ -- Micromet,Inc. , a biopharmaceutical company focusing on the development ofnovel, proprietary antibody-based products for cancer, inflammatoryand autoimmune diseases, today announced that Dr. Christian Itin,President and Chief Executive Officer of Micromet, Inc., willpresent at the 3rd Annual C.E. Unterberg, Towbin Emerging GrowthConf...

Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference

BOULDER, Colo.--(BUSINESS WIRE)--Jul 5, 2007 - Array BioPharma Inc.(Nasdaq: ARRY) today announced that its Chief Executive Officer,Robert E. Conway, will speak at the C.E Unterbeg, Towbin EmergingGrowth Conference on July 10 in New York City. The public iswelcome to participate in the conference through a webcast on theArray BioPharma website. -0- Event: C.E Unterbeg, Towbin E...

Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

BLOOMFIELD, N.J., July 05, 2007 /PRNewswire/ -- AlfacellCorporation today announced that Lawrence A. Kenyon, executive vicepresident, chief financial officer and corporate secretary, willpresent an overview of the company's product development programsat 8 a.m. EDT on Thursday, July 12, 2007, at the C.E. Unterberg,Towbin Emerging Growth Opportunities Conference in New York. The aud...

SuperGen to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

DUBLIN, Calif., July 06, 2007 /PRNewswire-FirstCall/ --SuperGen, Inc. today announced that Dr. Gregory Berk, Chief MedicalOfficer, will present at the C.E. Unterberg, Towbin Emerging GrowthOpportunities Conference on Thursday, July 12, 2007 at the MandarinOriental Hotel in New York City. SuperGen's presentation at the C.E. Unterberg, Towbin EmergingGrowth Opportunities Conference i...

ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

NEW YORK--(BUSINESS WIRE)--Jul 6, 2007 - ZIOPHARM Oncology, Inc.(NASDAQ: ZIOP) announced today that Dr. Jonathan Lewis, ChiefExecutive Officer, will present at the C.E. Unterberg, TowbinEmerging Growth Opportunities Conference on Thursday, July 12, 2007at 2:30 p.m. ET at the Mandarin Oriental Hotel, New York. Dr. Lewiswill provide an overview of the Company and an update on itsclinical deve...

Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference

FORT LEE, N.J.--(BUSINESS WIRE)--Jul 6, 2007 - Neurologix, Inc.(OTCBB:NRGX), a biotechnology company engaged in the development ofinnovative gene therapies for the brain and central nervous system,announced today that the company will present at the Third AnnualC.E. Unterberg Towbin Emerging Growth Conference on Tuesday July10, 2007 at 4:30 pm ET at The Mandarin Oriental Hotel in New York.<...

Neose Technologies to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

HORSHAM, Pa.--(BUSINESS WIRE)--Jul 9, 2007 - Neose Technologies,Inc. (NasdaqGM:NTEC) announced today that it will present at theC.E. Unterberg, Towbin Emerging Growth Opportunities Conferenceheld at the Mandarin Oriental Hotel in New York City from July10-12, 2007. The Company's presentation is scheduled for 2:00 p.m.(EDT) on Tuesday, July 10, 2007. The presentation will be webcastlive and...

Icagen to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Jul 9, 2007 -Icagen, Inc. (NASDAQ: ICGN) today announced that P. Kay Wagoner,Ph.D., Chief Executive Officer, will present at the C.E. Unterberg,Towbin Emerging Growth Opportunities Conference in New York City onThursday, July 12th at 2:00 p.m. ET. There will be a live webcast of this presentation from theconference. The webcast will be access...

Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference

RICHMOND, VA., July 9 /CNW/ - Insmed Inc. (NASDAQ:INSM), a biopharmaceutical company focused on the development and approvalof drugs for the treatment of metabolic diseases with unmetmedical needs, today announced that it will present at thisweek's C.E. Unterberg, Towbin (CEUT) Emerging GrowthOpportunities Conference in New York City. The conference, to be held at the Mandarin...

New Report 'Looking at Chiral Technologies' Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals

DUBLIN, Ireland--(BUSINESS WIRE)--Jun 21, 2007 - Research andMarkets (http://www.researchandmarkets.com/reports/c60415) hasannounced the addition of Looking at Chiral Technologies to theiroffering. The advancements in molecular research and continued untiringefforts of the research industry to develop better more preciselyapplicable Pharmaceuticals as well as agro compounds would have not...

Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin

VIENNA, Va., June 20, 2007 /PRNewswire/ -- Modigene Inc., aNevada corporation today announced the successful completion ofpharmacokinetic and pharmacodynamic pre-clinical experiments forlong-acting human growth hormone, long-acting interferon beta andlong-acting erythropoietin. Modigene's pharmacodynamic and pharmacokinetic pre-clinicalexperiments demonstrated superb durability of...

Doctors Outraged Over Growth Hormone Controversy

Two anti-aging preventative medicine doctors say they are outragedover recent media coverage about their advocacy of prescribinghuman growth hormone to treat a hormone deficiency often associatedwith aging. DAYTONA BEACH, Fla., April 27, 2007 /PRNewswire/ -- The adultuse of human growth hormone (HGH) was at the center of a recent NewYork Times article about the founders of the American Ac...

Data Presented at AACR Meeting Shows Peregrine's Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies

- New Studies Confirm That Fusion Proteins Made by CombiningCytokines With Peregrine's Anti-PS Antibodies Demonstrate IncreasedAnti-Tumor Activity With No Observable Toxicity - LOS ANGELES and TUSTIN, Calif., April 18, 2007/PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. , aclinical stage biopharmaceutical company developing targetedmonoclonal antibodies for the treatment of canc...

Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Both Hormone-Dependent and Hormone-Independent Prostate Cancer by Up to 94 Percent in Preclinical Studies

- Combination Therapy Significantly Decreased Tumor Blood VesselDensity and Serum PSA Levels in Prostate Tumors - LOS ANGELES and TUSTIN, Calif., April 17, 2007/PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. , aclinical stage biopharmaceutical company developing targetedmonoclonal antibodies for the treatment of cancer and hepatitis Cvirus (HCV) infection, today announced that p...

Preclinical Data Show Alfacell's Onconase Inhibits Tumor Growth of Non-Small Cell Lung Cancer, Breast Cancer Cells

Poster Presented at AACR Annual Meeting BLOOMFIELD, N.J., April 16, 2007 /PRNewswire-FirstCall/ --Alfacell Corporation today announced that in vivo and in vitropreclinical data presented in a poster at the American Associationfor Cancer Research (AACR) Annual Meeting show that ONCONASE(ranpirnase) significantly inhibits tumor growth of non-small celllung cancer (NSCLC) and breast cancer c...

Targanta Reports Improved Ability of Oritavancin to Stop Bacteria Growth In Vitro Compared With Other Glycopeptide Antibiotics

Three Oritavancin Studies Presented at ECCMID/ICC MUNICH, Germany, April 03, 2007 /PRNewswire/ -- TargantaTherapeutics today announced results from two studies showing theimproved potency of oritavancin to stop bacterial growth in vitrowhen tested with a common wetting agent (polysorbate 80) and onestudy demonstrating the activity of oritavancin against S.pneumoniae in a mouse model of pn...

Alzheimer's Growth Shows Need for Increased FDA Funding

Coalition for a Stronger FDA says drug review programs need moremoney WASHINGTON, March 21, 2007 /PRNewswire-USNewswire/ -- A newestimate by the Alzheimer's Association shows that more than fivemillion Americans are living with Alzheimer's disease -- a 10percent growth over previous estimates and a number that could morethan triple in the coming decades unless new treatments and curesare...